These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 32002637

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
    Agarwal S, Fuentes-Orrego JM, Arnason T, Misdraji J, Jhaveri KS, Harisinghani M, Hahn PF.
    AJR Am J Roentgenol; 2014 Oct; 203(4):W408-14. PubMed ID: 25055198
    [Abstract] [Full Text] [Related]

  • 23. A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma.
    Suh CH, Kim KW, Park SH, Shin S, Ahn J, Pyo J, Shinagare AB, Krajewski KM, Ramaiya NH.
    Eur Radiol; 2018 Jan; 28(1):214-225. PubMed ID: 28726119
    [Abstract] [Full Text] [Related]

  • 24. Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice.
    Jacob J, Deganello A, Sellars ME, Hadzic N, Sidhu PS.
    Ultraschall Med; 2013 Dec; 34(6):529-40. PubMed ID: 24132647
    [Abstract] [Full Text] [Related]

  • 25. Contrast-enhanced ultrasound features of histologically proven focal nodular hyperplasia: diagnostic performance compared with contrast-enhanced CT.
    Wang W, Chen LD, Lu MD, Liu GJ, Shen SL, Xu ZF, Xie XY, Wang Y, Zhou LY.
    Eur Radiol; 2013 Sep; 23(9):2546-54. PubMed ID: 23624595
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
    Purysko AS, Remer EM, Coppa CP, Obuchowski NA, Schneider E, Veniero JC.
    AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486
    [Abstract] [Full Text] [Related]

  • 31. Interest of contrast-enhanced sonography to identify focal nodular hyperplasia with sinusoidal dilatation.
    Alberti N, Frulio N, Bioulac-Sage P, Laumonier H, Balabaud C, Perez JT, Teixeira FR, Harbonnier N, Trillaud H.
    Diagn Interv Imaging; 2014 Jan; 95(1):77-83. PubMed ID: 24139183
    [Abstract] [Full Text] [Related]

  • 32. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA, Pedro MT, Ruivo C, Semedo LC, Marques C, Alves FC.
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [Abstract] [Full Text] [Related]

  • 33. Focal nodular hyperplasia and hepatocellular adenoma: The value of shear wave elastography for differential diagnosis.
    Brunel T, Guibal A, Boularan C, Ducerf C, Mabrut JY, Bancel B, Boussel L, Rode A.
    Eur J Radiol; 2015 Nov; 84(11):2059-64. PubMed ID: 26299323
    [Abstract] [Full Text] [Related]

  • 34. Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review.
    McInnes MD, Hibbert RM, Inácio JR, Schieda N.
    Radiology; 2015 Nov; 277(2):413-23. PubMed ID: 26020440
    [Abstract] [Full Text] [Related]

  • 35. 3D analysis is superior to 2D analysis for contrast-enhanced ultrasound in revealing vascularity in focal liver lesions - A retrospective analysis of 83 cases.
    Dong FJ, Xu JF, Du D, Jiao Y, Zhang L, Li M, Liu HY, Xiong Y, Luo H.
    Ultrasonics; 2016 Aug; 70():221-6. PubMed ID: 27235776
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Focal nodular hyperplasia and hepatocellular adenoma].
    Bastati-Huber N, Pötter-Lang S, Ba-Ssalamah A.
    Radiologe; 2015 Jan; 55(1):18-26. PubMed ID: 25575723
    [Abstract] [Full Text] [Related]

  • 38. Diagnostic accuracy and interobserver variability of Dynamic Vascular Pattern (DVP) in primary liver malignancies - A simple semiquantitative tool for the analysis of contrast enhancement patterns.
    Schellhaas B, Waldner MJ, Görtz RS, Vitali F, Kielisch C, Pfeifer L, Strobel D, Janka R, Neurath MF, Wildner D.
    Clin Hemorheol Microcirc; 2017 Jan; 66(4):317-331. PubMed ID: 28211805
    [Abstract] [Full Text] [Related]

  • 39. Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors.
    Tselikas L, Pigneur F, Roux M, Baranes L, Costentin C, Roche V, Calderaro J, Herin E, Laurent A, Zafrani E, Azoulay D, Mallat A, Rahmouni A, Luciani A.
    Abdom Radiol (NY); 2017 Mar; 42(3):825-832. PubMed ID: 27704147
    [Abstract] [Full Text] [Related]

  • 40. Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT.
    van den Esschert JW, Bieze M, Beuers UH, van Gulik TM, Bennink RJ.
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):436-40. PubMed ID: 20717825
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.